Compare CDNA & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | DRD |
|---|---|---|
| Founded | 1998 | 1895 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2007 | 2002 |
| Metric | CDNA | DRD |
|---|---|---|
| Price | $53.96 | $26.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $28.00 | ★ $32.63 |
| AVG Volume (30 Days) | ★ 1.0M | 262.0K |
| Earning Date | 04-28-2026 | 08-19-2026 |
| Dividend Yield | N/A | ★ 2.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $16.01 | $39.23 |
| Revenue Next Year | $11.31 | $30.12 |
| P/E Ratio | $25.48 | ★ $15.32 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $13.95 | $19.47 |
| 52 Week High | $55.16 | $39.37 |
| Indicator | CDNA | DRD |
|---|---|---|
| Relative Strength Index (RSI) | 69.87 | 46.95 |
| Support Level | $45.74 | $26.01 |
| Resistance Level | N/A | $27.25 |
| Average True Range (ATR) | 2.17 | 0.68 |
| MACD | -0.00 | -0.53 |
| Stochastic Oscillator | 85.84 | 23.89 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.